메뉴 건너뛰기




Volumn 33, Issue 4, 2014, Pages 301-308

Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: Network meta-analysis

Author keywords

Administration, oral; Anticoagulants; Thrombosis, prevention and control; Venous thromboembolism

Indexed keywords

APIXABAN; DABIGATRAN; PLACEBO; RIVAROXABAN; ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; MORPHOLINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE; THIOPHENE DERIVATIVE;

EID: 84925011405     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (20)

References (16)
  • 1
    • 0002181290 scopus 로고    scopus 로고
    • Epidemiology of venous thromboembolism
    • Kearon C. Epidemiology of venous thromboembolism. Semin Vase Med. 2001;1(1):7-26.
    • (2001) Semin Vase Med , vol.1 , Issue.1 , pp. 7-26
    • Kearon, C.1
  • 2
    • 0037704209 scopus 로고    scopus 로고
    • Natural history of venous thromboembolism
    • Jun 17
    • Kearon C. Natural history of venous thromboembolism. Circulation. Jun 17 2003; 107(23 Suppl 1):122-30.
    • (2003) Circulation , vol.107 , Issue.23 , pp. 122-130
    • Kearon, C.1
  • 3
    • 0033602514 scopus 로고    scopus 로고
    • A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
    • Mar 25
    • Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. Mar 25 1999; 340(12):901-907.
    • (1999) N Engl J Med , vol.340 , Issue.12 , pp. 901-907
    • Kearon, C.1    Gent, M.2    Hirsh, J.3
  • 4
    • 84874003257 scopus 로고    scopus 로고
    • Extended use of dabigatran, warfarin, or placebo in venous thromboembolism
    • Schulman S, Kearon C, Kakkar AK, et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. The New England journal of medicine. 2013;368(8):709-718.
    • (2013) The New England Journal of Medicine , vol.368 , Issue.8 , pp. 709-718
    • Schulman, S.1    Kearon, C.2    Kakkar, A.K.3
  • 7
    • 84861402643 scopus 로고    scopus 로고
    • Aspirin for preventing the recurrence of venous thromboembolism
    • May 24
    • Becattini C, Agnelli G, Schenone A, et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. May 24 2012;366(21):1959-1967.
    • (2012) N Engl J Med. , vol.366 , Issue.21 , pp. 1959-1967
    • Becattini, C.1    Agnelli, G.2    Schenone, A.3
  • 8
    • 84869441338 scopus 로고    scopus 로고
    • Low-dose aspirin for preventing recurrent venous thromboembolism
    • Nov 22
    • Brighton TA, Eikelboom JW, Mann K, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. Nov 22 2012;367(21):1979-1987.
    • (2012) N Engl J Med. , vol.367 , Issue.21 , pp. 1979-1987
    • Brighton, T.A.1    Eikelboom, J.W.2    Mann, K.3
  • 9
    • 68549101842 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate healthcare interventions: Explanation and elaboration
    • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed). 2009;339:10.
    • (2009) BMJ (Clinical Research Ed) , vol.339 , pp. 10
    • Liberati, A.1    Altman, D.G.2    Tetzlaff, J.3
  • 10
    • 84859001212 scopus 로고    scopus 로고
    • The Cochrane Collaborations tool for assessing risk of bias in randomised trials
    • Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaborations tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
    • (2011) BMJ , vol.343 , pp. d5928
    • Higgins, J.P.1    Altman, D.G.2    Gotzsche, P.C.3
  • 11
    • 23044505564 scopus 로고    scopus 로고
    • Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
    • Apr
    • Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. Apr 2005;3(4):692-694.
    • (2005) J Thromb Haemost , vol.3 , Issue.4 , pp. 692-694
    • Schulman, S.1    Kearon, C.2
  • 12
    • 0030793120 scopus 로고    scopus 로고
    • The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
    • Jun
    • Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. Jun 1997;50(6):683-691.
    • (1997) J Clin Epidemiol. , vol.50 , Issue.6 , pp. 683-691
    • Bucher, H.C.1    Guyatt, G.H.2    Griffith, L.E.3    Walter, S.D.4
  • 13
    • 21244495516 scopus 로고    scopus 로고
    • Indirect comparisons of competing interventions
    • Jul, iii-iv
    • Glenny AM, Altman DG, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess. Jul 2005;9(26): 1-134, iii-iv.
    • (2005) Health Technol Assess , vol.9 , Issue.26 , pp. 1-134
    • Glenny, A.M.1    Altman, D.G.2    Song, F.3
  • 14
    • 84869838484 scopus 로고    scopus 로고
    • Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: Direct and adjusted indirect meta-analysis of randomised controlled trials
    • Fox BD, Kahn SR, Langleben D, Eisenberg MJ, Shimony A. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ. 2012;345:e7498.
    • (2012) BMJ , vol.345 , pp. e7498
    • Fox, B.D.1    Kahn, S.R.2    Langleben, D.3    Eisenberg, M.J.4    Shimony, A.5
  • 15
    • 84872091789 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2013 update: A report from the American Heart Association
    • Jan 1
    • Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. Jan 1 2013;127(1):e6-e245.
    • (2013) Circulation , vol.127 , Issue.1 , pp. e6-e245
    • Go, A.S.1    Mozaffarian, D.2    Roger, V.L.3
  • 16
    • 77952524191 scopus 로고    scopus 로고
    • Systematic review: Case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism
    • May4
    • Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med. May4 2010;152(9):578-589.
    • (2010) Ann Intern Med , vol.152 , Issue.9 , pp. 578-589
    • Carrier, M.1    Le Gal, G.2    Wells, P.S.3    Rodger, M.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.